Profitability and Margin Expansion
Adjusted EBITDA of $119,000,000, up 4% year‑over‑year; adjusted EBITDA margin widened 90 basis points to 15.4%. Adjusted gross profit margin improved to 31.3%, up 170 basis points year‑over‑year. Adjusted EPS was $0.57, up 6% versus Q1 2025.
Raised Full‑Year Guidance
Updated fiscal 2026 guidance: net revenue expected up mid‑single digits; organic revenue expected up low single digits; adjusted EBITDA guidance raised to $645,000,000–$675,000,000; adjusted EPS now expected $4.55–$4.90. Q2 guidance: net revenue up low single digits and adjusted EBITDA $175,000,000–$185,000,000.
Decisive Pricing Actions
Announced a minimum 10% global price increase across all product lines effective April 1, with larger adjustments for certain technologies/regions. Management expects roughly 10%+ realized pricing for the remainder of the year and cited pricing as a major driver of the guidance upgrade.
Cash Flow and Leverage Improvement
Operating cash flow improved by $49,000,000 year‑over‑year in the quarter. Net debt to adjusted EBITDA was 3.1x (down from 3.5x a year earlier). Near‑term capital allocation shifted to share repurchases while maintaining target net debt/EBITDA of 2.5–3.0x.
Strong EA Segment Performance
Engineering Adhesives (EA) organic revenue increased ~3% in Q1 excluding solar; EA organic revenue declined 2% including solar. EA EBITDA increased 9% and EA EBITDA margin expanded 120 basis points to 19.9%.
Operational Sourcing Strengths and Early Share Gains
Company deployed global sourcing and supply assurance capabilities in response to Middle East disruptions; reported securing additional raw materials and noted instances of customers seeking H.B. Fuller for incremental supply (including three large global customers), creating near‑term share gain opportunities.
Project Quantum Leap Progress and Cost Actions
Restructuring and Project Quantum Leap continue to deliver savings. Company increased expected Quantum Leap benefit for the year from $10,000,000 to $15,000,000 and cited restructuring as a contributor to margin expansion.
Regional and Specialty Growth Pockets
Asia Pacific organic revenue was up ~2% excluding solar (Chinese New Year timing accounted for a $15–$20M Q1 impact). Medical business in Europe grew strongly (reported ~20% organic growth). Aerospace and general industries in the Americas showed continued strength (management noted an 8% year‑over‑year growth driver in those segments).